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Abstract: Only 25 to 30% of conceptions result in a live birth. There is mounting evidence that the cause for this low fe-
cundity is an extremely high incidence of chromosomal rearrangements occurring in the cleavage stage embryo. In this 
review, we gather all recent evidence for an extraordinary degree of mosaicisms in early embryogenesis. The presence of 
the rearrangements seen in the cleavage stage embryos can explain the origins of the placental mosaicisms seen during 
chorion villi sampling as well as the chromosomal anomalies seen in early miscarriages. Whereas these rearrangements 
often lead to implantation failure and early miscarriages, natural selection of the fittest cells in the embryo is the likely 
mechanism leading to healthy fetuses. 
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INTRODUCTION 
  Only 25 to 30% of conceptions result in a live birth [1]. 
The other 70-75% arrest at different stages of pregnancy, 
largely due to chromosome aberrations. Some aberrations are 
commonly found in prenatal diagnosis and analyses of mis-
carriages, but many are never detected or are only detected in 
a small percentage of the fetal cells. This shows that these 
rare aberrations do indeed occur at early stages of develop-
ment, but are selected against and are likely embryonic le-
thal. 
CHROMOSOME ERRORS IN HUMAN EMBRYOS 
  Chromosome instability is common in human in vitro 
fertilized (IVF) cleavage stage embryos. Over the past two 
decades due to the application of even better techniques for 
the analysis of the chromosome content of single blas-
tomeres chromosome instability has come to light. 
  Until recently, several studies of normally developing, 
good quality preimplantation embryos with fluorescent in 
situ hybridization (FISH) have shown that 45-70% of these 
embryos have a chromosomal abnormality (aneuploidy 
and/or polyploidy) in at least one cell [2-5]. When the results 
of different blastomeres of the same embryo are combined 
25% to more than 60% of embryos show mosaicism [2, 6-9]. 
These numbers are bound by a few limiting factors. FISH 
depends on fluorochromes that can be used on a nucleus si-
multaneously, usually 4 or 5. After analysis of the signals 
and washing off the probes, a second round with different 
probes can bring the number of chromosomes tested up to 
about 7 to 9. The most frequent protocols used only 3 to 6 
probes, targeting the chromosomes most commonly   
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found in spontaneous abortions. All other chromosomes are 
inherently missed and would raise the aberration rate if in-
cluded. Detection of segmental aberrations is also not possi-
ble with this standard FISH setup, because the probes used 
on embryos bind to alpha-satellite sequences at the centro-
mere or at a nearby locus. Detection of a third signal is gen-
erally interpreted as a trisomy for that chromosome, even if 
the cause could infact be a translocation, a marker, or an-
other aberration. 
  Since the introduction of comparative genomic hybridi-
zation (CGH), it has been possible to determine the copy 
number of all chromosomes in the nucleus of a blastomere 
[10, 11]. Because a measurement of the fluorescence is made 
over the entire length of the chromosome, it becomes possi-
ble to detect aneuploidy of segments of chromosomes. With 
this technique, the limit of detection per single cell lies 
around 40Mb, due to the amplification of DNA necessary to 
obtain a sufficient amount of DNA [12]. In 2000, two groups 
studied 12 normally developing embryos with CGH [13, 14] 
each. This amounted to ~65 available blastomeres per study. 
Both groups found abnormalities in 75% of embryos (9/12), 
confirming the high chromosome aberration rate from previ-
ous FISH studies. Most of these abnormal embryos (7/9 & 
8/9) had aneuploidy in some but not all analyzed cells, show-
ing a high frequency of mosaicism (78% & 89%). It was also 
demonstrated that the chromosomes not probed by FISH are 
indeed involved in cleavage stage aberrations. With the use 
of CGH, segmental aberrations were detected in early human 
embryos for the first time. Some clearly originated from 
post-zygotic events, with deletions and complementary du-
plications or even amplifications in different cells from the 
same embryo. Later studies confirmed both the high ane-
uploidy rate (~60%) and the segmental aberrations in cleav-
age stage embryos [15, 16]. 
  Array CGH uses the same principle as metaphase CGH, 
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patient and reference and measurement of patient/reference 
ratios. The technique was tested on the genomic content of 
single fibroblasts, EBVs (Ebstein Barr virus-transformed 
lymphoblastoid cells) and blastomeres. In a study of 23 nor-
mally developing, good quality preimplantation embryos 
(165 blastomeres), 91% (21/23) had chromosomal abnor-
malities. All abnormal embryos were mosaic, with combina-
tions of diploid and aneuploid cells (~50% of the embryos) 
or different and multiple types of aneuploidies. As with 
CGH, segmental aberrations could be detected, but they were 
unexpectedly found in 70% of the embryos. When array 
CGH was used in a study to screen 41 embryos from patients 
with at least 7 recurrent IVF failures by assessing 2 blas-
tomeres per embryo, abnormalities were detected in 60% of 
embryos [17]. FISH on additional blastomeres from affected 
embryos showed that the aberrations could not be confirmed 
in some instances in all blastomeres, pointing to mosaicism 
of these aberrations. A lower percentage of segmental aber-
rations was observed (5%). The presence of these segmental 
aneuploidies could be extrapolated from certain rare findings 
from prenatal diagnosis, spontaneous abortions or affected 
patients [18-20], but had not been proven in early human 
embryos before. 
  With such a high percentage of abnormalities found, the 
question arises whether these are true findings that would be 
seen in all early conceptions, or the result of a specific study 
group. Many studies on cleavage stage embryos used pa-
tients referred for fertility problems, but the same aberration 
rates were shown in the analysis of embryos from fertile pa-
tients undergoing PGD (Preimplantation Genetic Diagnosis) 
for sex selection, a single gene disorder or a familial mi-
crodeletion syndrome, without the indication of infertility [3, 
21]. Embryos from patients with a high maternal age could 
have more aberrations because of a high meiotic error rate. 
However, the finding that many of the abnormal embryos are 
a mixture of normal and aneuploid cells points towards a 
mitotic cause for the majority of those chromosomal errors. 
GENOMIC VARIATIONS IN PRENATAL DEVEL-
OPMENT 
  Many of the chromosomal aberrations seen in cleavage 
stage embryos are rarely, if ever, observed at the clinical 
stage of pregnancy. These include most monosomies, certain 
trisomies and the majority of segmental aberrations. Em-
bryos with these aberrations or with a multitude of aberra-
tions in different cells, as seen in the studies of Voullaire  
et al. (2000) [13], Wells & Delhanty (2000) [14] and Van-
neste  et al. (2009) [21], likely arrest before implantation. 
Aside from selection against abnormal embryos, it is also 
plausible that there is active selection against individual 
anomalous blastomeres or the possibility of active recruit-
ment of these abnormal blastomeres towards the placental 
tissues (Fig. 1). Several studies have shown that the degree 
of mosaicism and the aneuploidy rate are lower at blastocyst 
stage and that an embryo diagnosed as aneuploid at day 3 by 
FISH may still lead to a normally developing euploid blasto-
cyst [22-25]. However, a comparison of cells from the inner 
cell mass and the trophectoderm indicates there is no evi-
dence in blastocysts for preferential segregation of aberrant 
blastomeres to the trophectoderm. 
  The natural selection against abnormal embryos during 
the first days and weeks of gestation is reflected in a lower 
percentage of chromosomal abnormalities found in sponta-
neous abortions (50-60%) [26-28] compared to cleavage 
stage embryos (60-90%). The chromosomal constitution of 
















Fig. (1). The development of a human embryo to the blastocyst stage. The different colors at the eight cell stage represent mosaicism of nor-
mal blastomeres (green) and blastomeres carrying mitotically derived aneuploidies and mitotic structural aberrations (orange, red, blue and 
brown). When the embryo reaches blastocyst stage, the aberrant cells can be lost due to negative selection (a); they can segregate to the tro-
phectoderm only, leading to confined placental mosaicism (b); or they can be found in both the inner cell mass and the trophectoderm result-
ing in an embryo that is affected in certain tissues (c).  Somatic Genomic Variations in Early Human Prenatal Development  Current Genomics, 2010, Vol. 11, No. 6    399 
and all trisomies have been observed at least once. A number 
of trisomies are more commonly found (tris. 16, 21, 22), 
indicating that these are less detrimental during embryonic 
development. Autosomal monosomies are rarely detected at 
the clinical stage of pregnancy [27, 29-31]. The fact that 
these monosomy cases were often mosaic shows that these 
embryos survived through the first trimester because the 
monosomy was confined to the placental tissues or was only 
present in a smaller number of embryonic cells. Segmental 
aberrations appear in 4-7% of spontaneous abortions [31-35], 
which does not correlate with the high percentage found in 
cleavage stage embryos. The striking difference cannot be 
attributed to a difference in resolutions for array CGH and 
G-banding, as the detection limit lies around 10 Mb in array 
CGH on single cell material and around 5 Mb for G-banding 
on genomic miscarriage DNA. Several studies using array 
CGH [36-38] on products of conception (POC) have shown 
that small deletions and duplications are not a frequent cause 
of miscarriage and do not significantly increase the percent-
age of segmental aberrations in spontaneous abortions. Many 
of the analyzed cleavage stage embryos with segmental aber-
rations had multiple and/or complementary aberrations af-
fecting multiple cells and in combination with the other ane-
uploidies found in these embryos they likely arrested before 
implantation.  
  The presence of mosaicism has not been extensively in-
vestigated in spontaneous abortion samples. A study by Vor-
sanova et al. (2005) [39] using interphase FISH with probes 
for half of all chromosomes showed 30% mosaicism. This 
number is in contrast with mosaicism rates from other recent 
studies: 6% by Martinez et al. (2010) [40], and 3% by Rob-
berecht et al. (2009) [37]. It is also much higher than the 2-
5% as cited in the past [27, 41]. The lower percentages might 
be due to the exclusion of cases with mosaicism of aberrant 
female cells and normal female cells, as these cases are 
thought to be the result of maternal contamination. Another 
cause could be the selective nature of biopsies taken from 
products of conception. This would mean that tissue-specific 
or very low percentage aneuploidy might be missed. It war-
rants further research to confirm these results. 
  Prenatal diagnosis by chorionic villus sampling (CVS) or 
amniocentesis provides information on the chromosomal 
aberrations found beyond the first trimester. The percentage 
of chromosomal abnormalities detected by CVS lies around 
5% [42, 43]. However, this number is influenced by the spe-
cific indications for which CVS is performed: maternal age, 
presence of familial chromosome rearrangements or abnor-
malities seen on ultrasound. The incidence of mosaicism for 
chromosomal aberrations in CVS has been reported to be 
0.8-2% [42, 44, 45]. Only about 10-25% of these mosaics are 
confirmed in amniotic fluid (AF) or fetal blood [42, 46, 47]. 
They constitute cases of generalized mosaicism with true 
fetal involvement. The remaining 90% are categorized as 
confined placental mosaicism (CPM). The effect of CPM on 
the pregnancy varies greatly: some fetuses develop without 
problems; while others suffer from intra uterine growth re-
tardation or spontaneously abort. One must however be cau-
tious with CPM, because a number of cases without detec-
tion of the aberration in AF were shown to contain cryptic 
fetal mosaicism. Here, the trisomy was present in one or 
more tissues other than those sampled by AF cells, which did 
not always lead to a clinical phenotype [46, 48-50]. The ori-
gin of mosaicism at prenatal diagnosis has been investigated 
and both meiotic and postzygotic mitotic mechanisms were 
observed [46, 51, 52]. For cases of meiosis I or II origin, a 
trisomy rescue event resulted in the diploid cell line. In the-
ory, this should lead to uniparental disomy in one third of the 
cases. For certain chromosomes (e. g. 11, 15) this causes 
known genomic imprinting related defects. For other chro-
mosomes, for instance chromosome 16, the effect of the 
UPD remains unclear, as any phenotypic abnormalities seen 
in the fetus could be caused by placental insufficiency; these 
abnormalities are the same as those seen in fetuses with bi-
parental chromosome 16 inheritance and UPD16 has been 
found in fetuses that developed normally to term [53]. UPD 
may also lead to a loss of heterozygosity that could in turn 
activate recessive disease causing alleles. The underlying 
mechanism of origin and the frequency with which a CPM 
appears, differ from chromosome to chromosome and de-
pend on the viability of the specific chromosome and the 
percentage and different kinds of cell lineages that are af-
fected [46, 51, 52]. 
CONCLUSIONS 
  Studies using FISH, CGH and array CGH have clearly 
demonstrated that up to 90% of IVF embryos start with a 
burden of mitotic errors from the first cleavage divisions, 
including whole chromosomes and segmental aneuploidies. 
These embryos arrest or fail to implant and make up the first 
30% of embryos lost after conception [1]. There is hardly 
any data about the fate of embryos during the early weeks of 
pregnancy, after implantation but before clinical detection or 
even before the first missed menstrual period. Several stud-
ies of hysterectomy specimens and studies using daily urine 
hCG measurements, each in the normal fertile population, 
show that a further 30% of embryos are lost at this stage [1]. 
However, the genetic constitution of these embryos has not 
been investigated. One way to achieve this would be to do 
detection and follow-up of biochemical pregnancies by hCG 
level counts until a stagnation or drop in these levels indi-
cates an early miscarriage. A hysteroscopic embryoscopy 
can then be used to evaluate the morphology of the embryo 
in utero and to take a sample of embryonic tissue. This 
would allow both the correlation of morphologic abnormali-
ties with specific genetic conditions and the determination of 
the type of aberrations, both large and small, in embryos at 
this early stage. Taking an accurate biopsy of such early im-
plantation embryos will be technically challenging and it will 
be difficult to avoid maternal contamination. Another ap-
proach may be the in vitro culture of blastocysts. The growth 
and interaction of blastocysts with stromal cells in relation to 
their chromosomal constitution could then be followed [54, 
55]. 
  With a chromosome abnormality rate of 50-60% in spon-
taneous abortion samples and the detection of anatomic, 
hormonal or immunological causes in some recurrent abor-
tion cases, 40% of miscarriages still remain unexplained. 
Some could be the result of single gene disorders, both 
caused by mutations or chromosomal aberrations. These ge-
nomic errors occur de novo by chance and will likely be rare 
findings. One could also speculate that some of the copy 
number variations (CNV) commonly found in the general 400    Current Genomics, 2010, Vol. 11, No. 6  Robberecht et al. 
population are not tolerable in certain combinations. A 
Hardy-Weinberg disequilibrium could for example point to 
the lethal effect of a homozygous deletion or amplification 
of a specific CNV [56-58]. Future research is required to 
further elucidate the causes and mechanisms behind the 
many aberrations encountered throughout embryonic and 
fetal development [59-61]. 
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